Health Care & Life Sciences » Biotechnology | Shenzhen Neptunus Interlong Bio-Technique Co. Ltd.

Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
327
339
362
367
421
369
Total Accounts Receivable
147
164
229
217
231
238
Inventories
155
176
186
153
176
129
Other Current Assets
-
19
123
19
13
39
Total Current Assets
629
697
900
755
841
775
Net Property, Plant & Equipment
251
245
161
157
152
158
Total Investments and Advances
-
-
-
-
-
-
Long-Term Note Receivable
-
10
1
-
-
-
Intangible Assets
202
181
143
128
133
122
Other Assets
86
130
122
111
73
68
Total Assets
1,171
1,265
1,329
1,153
1,201
1,125
ST Debt & Current Portion LT Debt
122
234
219
122
47
Accounts Payable
99
115
114
75
85
Income Tax Payable
10
13
19
16
16
Other Current Liabilities
145
109
194
134
128
Total Current Liabilities
375
471
545
347
276
Long-Term Debt
35
-
-
-
-
Deferred Taxes
25
23
21
19
19
Total Liabilities
437
496
568
368
297
Common Equity (Total)
611
637
641
669
780
Total Shareholders' Equity
611
637
641
669
780
Total Equity
718
750
754
780
900
Liabilities & Shareholders' Equity
1,171
1,265
1,329
1,153
1,201
Accumulated Minority Interest
107
113
113
112
120
Non-Equity Reserves
16
19
6
5
4

About Shenzhen Neptunus Interlong Bio-Technique Co.

View Profile
Address
18th Floor, United Centre
Hong Kong
Hong Kong
Employees -
Website http://www.interlong.com
Updated 07/08/2019
Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. engages in the research and development, production and sales of medicines, the purchase and sales of medicines and healthcare food products. It operates through the following segments: Manufacturing and Selling of Medicines; Sales and Distribution of Medicines and Healthcare Products; and Provision of Research and Development Services of Modern Biological Technology. The company was founded on November 15, 1994 and is headquartered in Hong Kong.